Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1550 of 3546 entries
View as:

Effects of Salmeterol on Autonomic Nervous System

Phase: N/A Priority: Normal
NCT ID: NCT01536587 Org: User:
Start: 07/31/12 End: 11/30/12 Due: 11/30/13

Analysis of Trends Over Time of Hepatitis Related Incidence in Panama

Phase: N/A Priority: Normal
NCT ID: NCT01159951 Org: User:
Start: 01/31/09 End: 08/31/11 Due: 08/31/12

The Purpose of This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotriopium 18 mcg Once Daily Over a 24-week Treatment Period in Subjects With COPD

Phase: N/A Priority: Normal
NCT ID: NCT01777334 Org: User:
Start: 01/23/13 End: 09/24/13 Due: 09/24/14

Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers

Phase: N/A Priority: Normal
NCT ID: NCT00490568 Org: User:
Start: 08/08/07 End: 06/01/09 Due: 06/01/10

Efficacy and Safety Study in Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00980200 Org: User:
Start: 09/30/09 End: 01/31/10 Due: 01/31/11

A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT01154062 Org: User:
Start: 08/16/10 End: 04/29/11 Due: 04/29/12

Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT02224456 Org: User:
Start: 03/25/15 End: 12/04/20 Due: 12/04/21

Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT02946385 Org: User:
Start: 11/15/16 End: 02/13/18 Due: 02/13/19

Post-marketing Study to Evaluate the Efficacy of Influenza Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00197223 Org: User:
Start: 09/30/05 End: 05/31/06 Due: 05/31/07

Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00992992 Org: User:
Start: 06/28/01 End: 06/30/13 Due: 06/30/14

A Single Dose Of GSK189075 Taken By Mouth Containing Small Amounts Of Radioactivity Studied In Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00501683 Org: User:
Start: 11/30/06 End: - Due: -

Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y

Phase: N/A Priority: Normal
NCT ID: NCT00698906 Org: User:
Start: 06/30/97 End: - Due: -

[11C]Carfentanil PET Study of GSK1521498

Phase: N/A Priority: Normal
NCT ID: NCT00976066 Org: User:
Start: 06/15/09 End: 12/07/09 Due: 12/07/10

A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00452699 Org: User:
Start: 05/31/07 End: 05/31/09 Due: 05/31/10

Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.

Phase: N/A Priority: Normal
NCT ID: NCT00835237 Org: User:
Start: 02/17/09 End: 10/15/09 Due: 10/15/10

ELLIPTA™ vs. MDI Inhaler Preference Study, in Adult Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02135718 Org: User:
Start: 06/30/14 End: 07/31/14 Due: 07/31/15

A Study Of GW406381 In Volunteers With Moderate Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT00373243 Org: User:
Start: 10/19/05 End: 09/26/06 Due: 09/26/07

Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03248128 Org: User:
Start: 10/20/17 End: 03/21/22 Due: 03/21/23

Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1)

Phase: N/A Priority: Normal
NCT ID: NCT05630807 Org: User:
Start: 12/07/22 End: 05/08/26 Due: 05/08/27

Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT00463437 Org: User:
Start: 04/25/07 End: 06/14/08 Due: 06/14/09

A First Time in Human (FTIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK3884464 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05044325 Org: User:
Start: 09/20/21 End: 08/05/22 Due: 08/05/23

Primary & Booster Study in Infants to Demonstrate Non-inferiority, Persistence & Immunogenicity of Hib-MenC Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00327184 Org: User:
Start: 04/30/06 End: 11/30/06 Due: 11/30/07

A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response

Phase: N/A Priority: Normal
NCT ID: NCT04176939 Org: User:
Start: 12/09/19 End: 08/14/24 Due: 08/14/25

A Pharmacokinetic Study Of SB-681323 In Subjects With Coronary Heart Disease Undergoing Percutaneous Intervention

Phase: N/A Priority: Normal
NCT ID: NCT00291902 Org: User:
Start: 03/31/06 End: - Due: -

Japanese Phase 1 Study of Mepolizumab

Phase: N/A Priority: Normal
NCT ID: NCT01471327 Org: User:
Start: 08/09/11 End: 04/27/12 Due: 04/27/13